AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 32060651 — intervention group
Group type: EXPERIMENTAL
Intervention: Dimercaptopropane Sulfonate (DMPS) + Dimercaptosuccinic Acid (DMSA) (group 2)
Number of subjects: 100
Study 32060651 — intervention group
Group type: EXPERIMENTAL
Intervention: D-penicillamine (DPA) (group 1)
Number of subjects: 100
Study 32060651 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 100
Study 35347375 — intervention group
Group type: EXPERIMENTAL
Intervention: Isolated MPFL reconstruction (MPFL-R)
Number of subjects: 61
Study 35347375 — intervention group
Group type: COMPARATOR
Intervention: Active rehabilitation (Control)
Number of subjects: 61
Study 35347375 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (MPFL-R and Control)
Number of subjects: 61
Study 32013825 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair multimodal exercise (CME, n=20; 80±8.19)
Number of subjects: 60
Study 32013825 — intervention group
Group type: EXPERIMENTAL
Intervention: Chair elastic band muscle‐strength exercise (CSE, n=21; 81±4.79)
Number of subjects: 60
Study 32013825 — intervention group
Group type: COMPARATOR
Intervention: Control non‐exercise (CGne, n=19; 80±10.01)
Number of subjects: 60
Study 35076832 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent–Child Interaction Therapy (PCIT)
Number of subjects: 55
Study 35076832 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 55
Study 35660972 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab and chemotherapy
Number of subjects: 144
Study 35660972 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesothelioma risk score (MRS) based on high SII and low haemoglobin
Number of subjects: 144
Study 35660972 — intervention group
Group type: EXPERIMENTAL
Intervention: EORTC score
Number of subjects: 144
Study 33386288 — intervention group
Group type: EXPERIMENTAL
Intervention: Salvage radiation therapy with planning based on prostate-specific membrane antigen positron emission tomography/computed tomography
Number of subjects: 0
Study 33386288 — intervention group
Group type: COMPARATOR
Intervention: Salvage radiation therapy without planning based on prostate-specific membrane antigen positron emission tomography/computed tomography
Number of subjects: 0
Study 33047625 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise and computerized cognitive training (EX/CCT)
Number of subjects: 69
Study 32419678 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketamine infusion (0.2 mg/kg and 0.5 mg/kg)
Number of subjects: 71
Study 32419678 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ketamine infusion
Number of subjects: 71
Study 32419678 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline infusion)
Number of subjects: 71
Study 33121063 — intervention group
Group type: EXPERIMENTAL
Intervention: PleurX catheter
Number of subjects: 13
Study 33121063 — intervention group
Group type: COMPARATOR
Intervention: LVP
Number of subjects: 13
Study 34560136 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin 10 mg/day
Number of subjects: 4304
Study 34560136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 4304
Study 33421321 — intervention group
Group type: EXPERIMENTAL
Intervention: Off-label bevacizumab (q6w)
Number of subjects: 4536
Study 33421321 — intervention group
Group type: COMPARATOR
Intervention: Licensed aflibercept (q8w)
Number of subjects: 4536
Study 32673830 — intervention group
Group type: EXPERIMENTAL
Intervention: Accelerated antibiotic treatment (2 to 4 weeks)
Number of subjects: 0
Study 32673830 — intervention group
Group type: COMPARATOR
Intervention: Standard‐length antibiotic treatment (4 to 6 weeks)
Number of subjects: 0
Study 34029682 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferric maltol at 30mg twice daily for 16 weeks
Number of subjects: 167
Study 34029682 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 167
Study 34029682 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral ferric maltol at 30mg twice daily (continued treatment)
Number of subjects: 167
Study 34029682 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching from placebo to ferric maltol
Number of subjects: 167
Study 34029682 — intervention group
Group type: EXPERIMENTAL
Intervention: Ferric maltol
Number of subjects: 167
Study 35120149 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilisation techniques and soft tissue mobilisation techniques for 30 minutes per session, 10 weekly sessions, plus advice to stay active on their activities of daily living, information on physical activity, imaging tests, and sciatica for 5 biweekly sessions lasting 25‐30 minutes.
Number of subjects: 210
Study 35120149 — intervention group
Group type: COMPARATOR
Intervention: Advice to stay active only.
Number of subjects: 210
Study 35120149 — intervention group
Group type: EXPERIMENTAL
Intervention: Neural mobilisation techniques and soft tissue mobilisation techniques plus advice to stay active.
Number of subjects: 210
Study 33583120 — intervention group
Group type: EXPERIMENTAL
Intervention: q2m belatacept
Number of subjects: 166
Study 33583120 — intervention group
Group type: COMPARATOR
Intervention: q1m belatacept
Number of subjects: 166
Study 32887558 — intervention group
Group type: EXPERIMENTAL
Intervention: Sauti ya Vijana (SYV) intervention
Number of subjects: 128
Study 32887558 — intervention group
Group type: COMPARATOR
Intervention: Standard-of-Care (SOC)
Number of subjects: 128
Study 35256034 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-visiting intervention during pregnancy
Number of subjects: 32
Study 33962320 — intervention group
Group type: EXPERIMENTAL
Intervention: Straight-sided glasses (A)
Number of subjects: 24
Study 33962320 — intervention group
Group type: COMPARATOR
Intervention: Usual, predominantly curved glasses (B)
Number of subjects: 24
Study 33962320 — intervention group
Group type: EXPERIMENTAL
Intervention: Comparison of A and B
Number of subjects: 24
Study 32520870 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (low dose: 33.6 kJ·kg body weight per week)
Number of subjects: 61
Study 32520870 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (moderate dose: 58.8 kJ·kg body weight per week)
Number of subjects: 61
Study 32520870 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (moderate dose)
Number of subjects: 61
Study 32520870 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate-intensity walking (low dose)
Number of subjects: 61
Study 36444207 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone 0.4 mg intracanalicular insert (DEX)
Number of subjects: 20
Study 36444207 — intervention group
Group type: COMPARATOR
Intervention: Topical prednisolone acetate (PRED)
Number of subjects: 20
Study 32808022 — intervention group
Group type: EXPERIMENTAL
Intervention: Uric acid
Number of subjects: 0
Study 32808022 — intervention group
Group type: EXPERIMENTAL
Intervention: Paraxanthine
Number of subjects: 0
Study 34852928 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-maintained propofol TCI sedation (PMPS)
Number of subjects: 80
Study 34852928 — intervention group
Group type: COMPARATOR
Intervention: Anaesthetist-controlled propofol TCI sedation (ACPS)
Number of subjects: 80
Study 32634360 — intervention group
Group type: EXPERIMENTAL
Intervention: Earned Income Tax Credit of up to $2,000 (treatment)
Number of subjects: 5968
Study 32634360 — intervention group
Group type: COMPARATOR
Intervention: Standard Earned Income Tax Credit of about $500 (control)
Number of subjects: 5968
Study 34519136 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspirin, paracetamol, and caffeine (APC)
Number of subjects: 3306
Study 34519136 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3306
Study 33886430 — intervention group
Group type: COMPARATOR
Intervention: Trigger-based vaccination (TRV)
Number of subjects: 6000
Study 33886430 — intervention group
Group type: COMPARATOR
Intervention: SO plus vaccination started randomly on Days 11–35 of the response (VACr)
Number of subjects: 6000
Study 33886430 — intervention group
Group type: COMPARATOR
Intervention: SO plus vaccination with a fixed start on Day 21 of the response (VACf)
Number of subjects: 6000
Study 33886430 — intervention group
Group type: EXPERIMENTAL
Intervention: SO only
Number of subjects: 6000
Study 32773545 — intervention group
Group type: EXPERIMENTAL
Intervention: Resisted sled-pull training (light, moderate, heavy)
Number of subjects: 53
Study 32773545 — intervention group
Group type: EXPERIMENTAL
Intervention: Heavy resisted sled-pull training
Number of subjects: 53
Study 32773545 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate to heavy resisted sled-pull training
Number of subjects: 53
Study 32773545 — intervention group
Group type: COMPARATOR
Intervention: Unresisted sprinting
Number of subjects: 53
Study 32773545 — intervention group
Group type: EXPERIMENTAL
Intervention: All resisted groups
Number of subjects: 53
Study 35778834 — intervention group
Group type: EXPERIMENTAL
Intervention: BT‐001 digital therapeutic (CBT)
Number of subjects: 0
Study 35778834 — intervention group
Group type: COMPARATOR
Intervention: Control app
Number of subjects: 0
Study 32828687 — intervention group
Group type: COMPARATOR
Intervention: Heat application group (HAG)
Number of subjects: 90
Study 35977775 — intervention group
Group type: EXPERIMENTAL
Intervention: Watch Me Grow Integrated (WMG-I) approach for developmental screening
Number of subjects: 2000
Study 35977775 — intervention group
Group type: COMPARATOR
Intervention: Surveillance as Usual (SaU)
Number of subjects: 2000
Study 34349369 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound guidance (Group U)
Number of subjects: 80
Study 34349369 — intervention group
Group type: COMPARATOR
Intervention: Conventional palpatory method (Group P)
Number of subjects: 80
Study 34349369 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 80
Study 36220461 — intervention group
Group type: EXPERIMENTAL
Intervention: CRT-TEM
Number of subjects: 173
Study 36220461 — intervention group
Group type: COMPARATOR
Intervention: TME
Number of subjects: 173
Study 32598093 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive antidepressant treatment
Number of subjects: 763
Study 32598093 — intervention group
Group type: COMPARATOR
Intervention: Nonusers of antidepressants
Number of subjects: 763
Study 32598093 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive antidepressant treatment (late starters excluded)
Number of subjects: 763
Study 32720628 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem Management Plus (PM+)
Number of subjects: 346
Study 32720628 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Usual Care (EUC)
Number of subjects: 346
Study 36501066 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrulline 3 g
Number of subjects: 18
Study 36501066 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrulline 6 g
Number of subjects: 18
Study 36501066 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 33630662 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined memory treatment (traditional episodic memory therapy + semantic memory-focused therapy)
Number of subjects: 25
Study 33630662 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control group
Number of subjects: 25
Study 35448469 — intervention group
Group type: COMPARATOR
Intervention: 10 g sucrose (S‐group)
Number of subjects: 11
Study 35448469 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g whey protein + 10 g sucrose (W‐S‐group)
Number of subjects: 11
Study 35448469 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 g whey protein (W‐group)
Number of subjects: 11
Study 34666419 — intervention group
Group type: EXPERIMENTAL
Intervention: RYGB + Exercise Training (ET)
Number of subjects: 80
Study 34666419 — intervention group
Group type: EXPERIMENTAL
Intervention: RYGB + ET
Number of subjects: 80
Study 34666419 — intervention group
Group type: COMPARATOR
Intervention: RYGB
Number of subjects: 80
Study 35750249 — intervention group
Group type: EXPERIMENTAL
Intervention: Rifaximin SSD IR 40 mg once-nightly
Number of subjects: 587
Study 35750249 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactulose plus rifaximin SSD IR 40 mg bid
Number of subjects: 587
Study 35750249 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 587
Study 35750249 — intervention group
Group type: COMPARATOR
Intervention: Lactulose plus placebo
Number of subjects: 587
Study 32893328 — intervention group
Group type: EXPERIMENTAL
Intervention: Fingolimod (0.5 mg/day)
Number of subjects: 40
Study 32893328 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 40
Study 32345344 — intervention group
Group type: EXPERIMENTAL
Intervention: MiLES intervention (online toolbox for employers during RTW process)
Number of subjects: 90
Study 32345344 — intervention group
Group type: COMPARATOR
Intervention: Care as usual from employer
Number of subjects: 90
Study 33003227 — intervention group
Group type: EXPERIMENTAL
Intervention: Adjunctive azithromycin
Number of subjects: 1916
Study 33003227 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1916
Study 34610541 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative methylprednisolone (40 mg or 120 mg)
Number of subjects: 180
Study 34610541 — intervention group
Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 180
Study 32272030 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-based physical therapy plus dry needling
Number of subjects: 116
Study 32272030 — intervention group
Group type: COMPARATOR
Intervention: Guideline-based physical therapy
Number of subjects: 116
Study 34157188 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental diet therapy (EDT) using an amino acid‐based formula
Number of subjects: 4
Study 35544051 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedle array (MNA-25%) - 0.63 µg per patch, administered twice, 3 weeks apart
Number of subjects: 39
Study 35544051 — intervention group
Group type: EXPERIMENTAL
Intervention: Microneedle array (MNA-10%) - 0.25 µg per patch, administered twice, 3 weeks apart
Number of subjects: 39
Study 35544051 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous injection - 2.5 µg per injection, administered twice, 3 weeks apart
Number of subjects: 39
Study 34578973 — intervention group
Group type: EXPERIMENTAL
Intervention: Caloric restriction with n-3 PUFA supplementation (1.8 g/day)
Number of subjects: 64
Study 34578973 — intervention group
Group type: COMPARATOR
Intervention: Caloric restriction without n-3 PUFA supplementation (placebo)
Number of subjects: 64
Study 33079196 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.4 mg/g VLNC cigarettes
Number of subjects: 775
Study 33079196 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.4 mg/g VLNC cigarettes
Number of subjects: 775
Study 33079196 — intervention group
Group type: COMPARATOR
Intervention: 15.8 mg/g control cigarettes
Number of subjects: 775
Study 34479188 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative halo-femoral traction (IOHFT)
Number of subjects: 29
Study 34479188 — intervention group
Group type: COMPARATOR
Intervention: Control (nontraction) group
Number of subjects: 29
Study 33713235 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose ozone therapy
Number of subjects: 0
Study 34981361 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathic communication
Number of subjects: 30
Study 34981361 — intervention group
Group type: EXPERIMENTAL
Intervention: Shared decision-making
Number of subjects: 30
Study 34981361 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Support Analysis Tool (DSAT)
Number of subjects: 30
Study 34981361 — intervention group
Group type: EXPERIMENTAL
Intervention: Empathic Communication Coding System (ECCS)
Number of subjects: 30
Study 35096723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy at 6 L/min for 6-12 hours
Number of subjects: 6629
Study 35096723 — intervention group
Group type: COMPARATOR
Intervention: Ambient air
Number of subjects: 6629
Study 35096723 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxygen therapy
Number of subjects: 6629
Study 32383771 — intervention group
Group type: EXPERIMENTAL
Intervention: Urinary FSH (uFSH) bolus (6 ampules, 450 IU)
Number of subjects: 732
Study 32383771 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 732
Study 35830201 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC plus arbidol tablets (200 mg three times a day for 14 days)
Number of subjects: 99
Study 35830201 — intervention group
Group type: EXPERIMENTAL
Intervention: SOC plus arbidol tablets
Number of subjects: 99
Study 35830201 — intervention group
Group type: COMPARATOR
Intervention: SOC
Number of subjects: 99
Study 32794087 — intervention group
Group type: EXPERIMENTAL
Intervention: Peer and non-peer co-facilitated intervention (Living Well)
Number of subjects: 16
Study 34009795 — intervention group
Group type: EXPERIMENTAL
Intervention: Educational workshop for coaches (60-minute duration)
Number of subjects: 21
Study 34009795 — intervention group
Group type: COMPARATOR
Intervention: Control group received print materials only
Number of subjects: 21
Study 33385772 — intervention group
Group type: EXPERIMENTAL
Intervention: Expressive arts therapy (EAT), 60-90 min, twice a week for 6 weeks
Number of subjects: 48
Study 33385772 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control
Number of subjects: 48
Study 32658308 — intervention group
Group type: EXPERIMENTAL
Intervention: Fatty acid isotopic sentinels (FAME) prepared at a ratio of 2:1
Number of subjects: 0
Study 32658308 — intervention group
Group type: EXPERIMENTAL
Intervention: Catalytic amounts of NaOCH3
Number of subjects: 0
Study 35713650 — intervention group
Group type: EXPERIMENTAL
Intervention: Reading aloud
Number of subjects: 26
Study 35713650 — intervention group
Group type: EXPERIMENTAL
Intervention: Semi-occluded vocal tract exercises (SOVTE)
Number of subjects: 26
Study 35713650 — intervention group
Group type: COMPARATOR
Intervention: SOVTE
Number of subjects: 26
Study 33805948 — intervention group
Group type: EXPERIMENTAL
Intervention: Interferential current (IFC) application on the lumbar segment
Number of subjects: 73
Study 33805948 — intervention group
Group type: COMPARATOR
Intervention: Placebo intervention
Number of subjects: 73
Study 35395840 — intervention group
Group type: EXPERIMENTAL
Intervention: Advice to visit the general practitioner cooperative
Number of subjects: 0
Study 35395840 — intervention group
Group type: COMPARATOR
Intervention: Nurse's advice
Number of subjects: 0
Study 33180100 — intervention group
Group type: EXPERIMENTAL
Intervention: Preoperative radiotherapy regimen of 36 Gy in once-daily 2-Gy fractions
Number of subjects: 79
Study 35836691 — intervention group
Group type: EXPERIMENTAL
Intervention: Increased raw vegetable intake through seminars and intensive coaching weekly
Number of subjects: 84
Study 35836691 — intervention group
Group type: COMPARATOR
Intervention: Conventional diabetes diet according to the guidelines of the Indonesian Society of Endocrinology
Number of subjects: 84
Study 33646341 — intervention group
Group type: EXPERIMENTAL
Intervention: Intoxicated group (mean BrAC = 0.06% at encoding, 0.07% at retrieval)
Number of subjects: 165
Study 33646341 — intervention group
Group type: COMPARATOR
Intervention: Active placebo group
Number of subjects: 165
Study 33646341 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 165
Study 33646341 — intervention group
Group type: EXPERIMENTAL
Intervention: Intoxicated group
Number of subjects: 165
Study 35997951 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation (3000 mg daily in three divided doses for five days)
Number of subjects: 75
Study 35997951 — intervention group
Group type: EXPERIMENTAL
Intervention: L-carnitine supplementation
Number of subjects: 75
Study 35997951 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard hospital treatment only)
Number of subjects: 75
Study 34791048 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard RYGB (150 cm alimentary, 50 cm biliopancreatic limb)
Number of subjects: 123
Study 34791048 — intervention group
Group type: EXPERIMENTAL
Intervention: Distal RYGB (150 cm common channel, 50 cm biliopancreatic limb)
Number of subjects: 123
Study 34791048 — intervention group
Group type: COMPARATOR
Intervention: Between-group comparison
Number of subjects: 123
Study 34292408 — intervention group
Group type: EXPERIMENTAL
Intervention: Noninvasive ventilation
Number of subjects: 91
Study 34292408 — intervention group
Group type: COMPARATOR
Intervention: High-flow nasal oxygen
Number of subjects: 91
Study 33127579 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tFUS (sonication of the right anterior thalamus)
Number of subjects: 19
Study 33127579 — intervention group
Group type: COMPARATOR
Intervention: Sham tFUS
Number of subjects: 19
Study 35876109 — intervention group
Group type: EXPERIMENTAL
Intervention: 2,4-D herbicide at a dose of 2.04 g a.e. ha-1
Number of subjects: 0
Study 35876109 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of 2,4-D applied at tillering stage
Number of subjects: 0
Study 35876109 — intervention group
Group type: EXPERIMENTAL
Intervention: Low doses of 2,4-D
Number of subjects: 0
Study 34333788 — intervention group
Group type: EXPERIMENTAL
Intervention: Intragastric balloon therapy
Number of subjects: 0
Study 34333788 — intervention group
Group type: EXPERIMENTAL
Intervention: Endoscopic sleeve gastroplasty
Number of subjects: 0
Study 32478821 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental intervention (various invasive cardiovascular interventions)
Number of subjects: 216
Study 32478821 — intervention group
Group type: COMPARATOR
Intervention: Nonsignificant differences in primary outcomes
Number of subjects: 216
Study 32478821 — intervention group
Group type: COMPARATOR
Intervention: Commercial sponsorship
Number of subjects: 216
Study 32478821 — intervention group
Group type: COMPARATOR
Intervention: Discrepancies between registered and published primary outcomes
Number of subjects: 216
Study 32478821 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients experiencing a different outcome
Number of subjects: 216
Study 34837259 — intervention group
Group type: EXPERIMENTAL
Intervention: Formula total diet replacement programme followed by structured weight loss maintenance
Number of subjects: 22
Study 34837259 — intervention group
Group type: EXPERIMENTAL
Intervention: Support by healthcare professionals (HCPs)
Number of subjects: 22
Study 34837259 — intervention group
Group type: EXPERIMENTAL
Intervention: Ongoing support by research dietitians
Number of subjects: 22
Study 33180129 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted review by pathologists
Number of subjects: 240
Study 33180129 — intervention group
Group type: COMPARATOR
Intervention: Unassisted review by pathologists
Number of subjects: 240